Found: 20
Select item for more details and to access through your institution.
Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19).
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e526, doi. 10.1093/cid/ciac512
- By:
- Publication type:
- Article
Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 7, p. 1275, doi. 10.1093/cid/ciab643
- By:
- Publication type:
- Article
Fecal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) RNA Is Associated With Decreased Coronavirus Disease 2019 (COVID-19) Survival.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 6, p. 1081, doi. 10.1093/cid/ciab623
- By:
- Publication type:
- Article
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Sequence Characteristics of Coronavirus Disease 2019 (COVID-19) Persistence and Reinfection.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 2, p. 237, doi. 10.1093/cid/ciab380
- By:
- Publication type:
- Article
Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 2, p. 394, doi. 10.1093/infdis/jiae192
- By:
- Publication type:
- Article
Variant-Specific Viral Kinetics in Acute COVID-19.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S136, doi. 10.1093/infdis/jiad314
- By:
- Publication type:
- Article
Virologic Features of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Detection of the Omicron Variant Virus With the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 3, p. 1, doi. 10.1093/ofid/ofac022
- By:
- Publication type:
- Article
Uncovering hidden sources of SARS‐CoV‐2 viral evolution: A call to action.
- Published in:
- Transplant Infectious Disease, 2022, v. 24, n. 6, p. 1, doi. 10.1111/tid.13910
- By:
- Publication type:
- Article
Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-32551-2
- By:
- Publication type:
- Article
SARS-CoV-2 Virologic Rebound With Nirmatrelvir–Ritonavir Therapy: An Observational Study.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 12, p. 1577, doi. 10.7326/M23-1756
- By:
- Publication type:
- Article
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 5, p. 658, doi. 10.7326/M22-3428
- By:
- Publication type:
- Article
Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection.
- Published in:
- Annals of Internal Medicine, 2023, v. 176, n. 3, p. 348, doi. 10.7326/M22-2381
- By:
- Publication type:
- Article
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 4, p. 1, doi. 10.1371/journal.ppat.1011680
- By:
- Publication type:
- Article
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 731, p. 1, doi. 10.1126/scitranslmed.adk1599
- By:
- Publication type:
- Article
Genome‐wide association analysis of COVID‐19 mortality risk in SARS‐CoV‐2 genomes identifies mutation in the SARS‐CoV‐2 spike protein that colocalizes with P.1 of the Brazilian strain.
- Published in:
- Genetic Epidemiology, 2021, v. 45, n. 7, p. 685, doi. 10.1002/gepi.22421
- By:
- Publication type:
- Article
SYMPTOM AND VIRAL REBOUND IN UNTREATED COVID-19 INFECTION.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 70
- By:
- Publication type:
- Article
CHARACTERIZATION OF SINGLE VERSUS DUAL ACTIVE mAB AGAINST SARS-CoV-2.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 69
- By:
- Publication type:
- Article
Impact of pre-existing drug resistance on risk of virological failure in South Africa.
- Published in:
- 2021
- By:
- Publication type:
- journal article